Total Visits

Views
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer73

Select a period of time:

Views

Views
May 20251
June 20253
July 202529
August 20252
September 20253
October 20251
November 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States15
Brazil12
Turkey2
Austria2
Argentina1
Dominican Republic1
United Kingdom1
Hong Kong1
Jamaica1
Morocco1
 

Top cities views

Views
Dallas3
Istanbul2
Arapongas1
Bagé1
Bebedouro1
Belvidere1
Caraguatatuba1
Casablanca1
Cheltenham1
Cleveland1